PHARMACEUTICAL PRODUCT DEVELOPMENT INC 4
4 · PHARMACEUTICAL PRODUCT DEVELOPMENT INC · Filed Feb 15, 2006
Insider Transaction Report
Form 4
DAVENPORT FRED B JR
President
Transactions
- Exercise/Conversion
Stock Options (to buy)
2006-02-14−17,500→ 195,000 totalExercise: $26.22From: 2004-12-03Exp: 2011-12-02→ Common Stock (17,500 underlying) - Sale
Common Stock
2006-02-14$67.10/sh−3,500$234,850→ 52,866 total - Sale
Common Stock
2006-02-14$66.56/sh−14,000$931,840→ 38,866 total - Exercise/Conversion
Common Stock
2006-02-14$26.22/sh+17,500$458,850→ 56,366 total
Footnotes (1)
- [F1]7,500 options were vested and exercisable on 12/3/02; 7,500 options were vested and exercisable on 12/3/03 and 2,500 options were exercisable and vested on 12/3/04.